Cardiac arrest & resuscitation

Efficacy and safety of corticosteroids in cardiac arrest: a systematic review, meta-analysis and trial sequential analysis of randomized control trials

Crit CarePublished Systematic review and meta-analysis of randomised trials

Pooled result · MortalityResult — go to the resultRelative risk 0.96 95% CI 0.90–1.02

Authors' conclusion

In patients during or after cardiac arrest, corticosteroids have an uncertain effect on mortality but probably increase ROSC and may increase the likelihood of survival with good functional outcome at hospital discharge.

Study context

Population
Patients following in- and out-of-hospital cardiac arrest
Participants
2,213 patients · 8 randomized controlled trials (RCTs)
Comparison
Corticosteroids vs placebo or usual care
Outcome
Mortality at the longest point of follow-up
Follow-up
Longest point
Methodological detailsrandom effects meta-analysis, trial sequential analysis, GRADE certainty of evidence
  • Random effects meta-analysis
  • Trial sequential analysis
  • GRADE certainty of evidence

Pooled result

Mortality

Relative risk

0.96

95% CI 0.90–1.02

Corticosteroids vs Placebo or usual care
RR 0.96 (95% CI 0.90–1.02)

As reported in the abstract

Further pooled results

OutcomeEstimate
ROSCModerate certaintyRR for ROSC 1.32 (95% CI 1.18–1.47)
Survival with good functional outcomeLow certaintyRR for survival with good functional outcome 1.49 (95% CI 0.87–2.54)

Safety

OutcomeRR (95% CI)
VAPLow certainty0.76 (0.46–1.09)
Renal failureLow certainty1.29 (0.84–1.99)
BleedingVery low certainty2.04 (0.53–7.84)
PeritonitisVery low certainty10.54 (2.99–37.19)

Original publication

Efficacy and safety of corticosteroids in cardiac arrest: a systematic review, meta-analysis and trial sequential analysis of randomized control trials. Crit Care. Published 11 January 2023. doi:10.1186/s13054-022-04297-2

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.